News archive
September 2009
Search |
2009 Now |
Jan |
Feb |
Mar |
Apr |
May |
Jun |
Jul | Aug
2008 |
Dec |
Nov |
Oct |
Sep |
Aug |
Jul |
Jun |
May |
Apr |
Mar |
Feb |
Jan
2008 |
2007 |
2006 |
2005
Cancer awareness scheme launched at English
football clubs
A new scheme launched today at five English football clubs will help
educate men about the symptoms and risks of ‘male’ cancers — prostate,
lung and bowel cancer — and encourage them to go to their doctor earlier
when they show the symptoms. 26 Sept 2009
Revolutionary antibody technology gives
hope for vaccine against genetically diverse HIV
For the first time an antigen has been created that induces protective
antibodies capable of blocking infection of human cells by
genetically-diverse strains of the human immunodeficiency virus (HIV).
25 Sept 2009
Thailand
HIV vaccine trial first to show preventive effect
The world's largest clinical trial of an investigational vaccine regimen
has shown that it is well-tolerated and has a modest effect in
preventing HIV infection in strains present in Thailand. 25 Sept 2009
METRC calls for project proposals in the
"science of everyday things"
METRC the N8 Molecular Engineering Translational Research Centre based
at Sheffield University, has launched its Autumn 2009 Proof of Concept
Funding Call for industry–academic partnership projects. Up to £50,000
is available for each project. 23 Sept 2009
InVitria launches Optiferrin for mammalian
cell culture
Optiferrin is a cell culture supplement which supports cell growth by
regulating the amount of iron transported to the cell. 23 Sept 2009
AorTech licenses heart valve to SynCardia
for use in artificial heart
This agreement licenses the use of AorTech’s Elast-Eon polymer heart
valve (PHV) in the SynCardia Total Artificial Heart, as well as the
company’s future family of pulsatile products. 23 Sept 2009
Touch
Bionics wins silver medal in Wall Street Journal Technology Innovation
Awards
Scottish company Touch Bionics, developer of the world’s first
multi-articulating bionic hand, has won silver in the 2009 Wall Street
Journal Technology Innovation Awards and also won top honours in the
Medical-Devices category for its i-LIMB Hand. 23 Sept 2009
Phico Therapeutics reaches first human
clinical trials with novel MRSA-beating antibacterial technology
The new technology is based on the antibiotic protein SASP which is
delivered into the target bacterial cells by bacteriophages. 23 Sept
2009
Siemens introduces dedicated ultrasound
system for obstetrics and gynecology
Siemens Healthcare has introduced a dedicated ultrasound system for
obstetrics and gynaecology, the Acuson X300 ultrasound system,
PremiumEdition (PE) — Women’s Imaging. The system features exceptional
clinical performance across all modes, including 3D/4D imaging. 23 Sept
2009
Hamilton launches ARC sensor technology for
fluid measurement
Hamilton Company, a producer of precision fluid measurement devices, has
announced the Hamilton ARC concept, a new sensor family for process
control that includes pH, dissolved oxygen and conductivity
measurements. 23 Sept 2009
Chimpanzees
trained to help DNA research
Geneticists at Leicester University are receiving willing assistance
from chimpanzees at Twycross Zoo. The chimps have been trained to enable
keepers to take their DNA samples with cheek swabs. 23 Sept 2009
HIV vaccine a step closer with discovery of
new potent antibodies
Two powerful new antibodies to HIV that reveal what may be an Achilles
heel on the virus have been found. Researchers will now try to exploit
the newfound vulnerability on the virus to craft novel approaches to
designing an AIDS vaccine. 22 Sept
Cepheid accelerates development of rapid
flu A panel test
Cepheid has announced the accelerated development of a Flu A Panel test
for use on the GeneXpert System. The test will be designed to provide
45-minute identification of flu A infection, with specific presumptive
identification of seasonal H1, seasonal H3, and H1N1 novel strain types.
22 Sept 2009
Pandemic flu H1N1 can cause more severe
lung infection than seasonal flu
Pandemic swine flu can infect cells deeper in the lungs than seasonal
flu, which may explain why people infected with the pandemic strain of
H1N1 influenza are more likely to suffer more severe symptoms than those
infected with the seasonal strain of H1N1. 21 Sept 2009
Large differences in cardiovascular mortality and national prevention
policies across EU
Research from a three-year programme to analyse cardiovascular health
and prevention policies in 16 European countries shows heart disease
remains the leading cause of death in Europe but there are huge
differences in both national prevention policies and levels
of cardiovascular mortality between countries. 21 Sept 2009
Functioning model of human brain could be
built within 10 years
A model that replicates the functions of the human brain is feasible in
10 years, according to neuroscientist Professor Henry Markram of the
Brain Mind Institute in Switzerland. 21 Sept 2009
Cardinal Health spin-off CareFusion starts
trading on NYSE
CareFusion Corp. was launched as an independent, publicly traded company
at the beginning of the month. CareFusion products include Pyxis
automated dispensing systems, Alaris IV pumps, ChloraPrep V. Mueller
surgical instruments. 21 Sept 2009
eBioscience corporation acquires NatuTec
GmbH
eBioscience Corporation, a San Diego-based producer of cell analysis
reagents to biotechnology laboratories has announced the acquisition of
Frankfurt-based NatuTec GmbH, a distributor of high-quality biological
research reagents. 21 Sept 2009.
Abbott to acquire cardiac valve device
company Evalve
The acquisition provides Abbott with a presence in the growing area of
non-surgical treatment for structural heart disease for a cost of up to
$410 million. 21 Sept 2009
US FDA approves four vaccines for 2009 H1N1
influenza virus
The US Food and Drug Administration (FDA) has announced that it has
approved four vaccines against the 2009 H1N1 influenza virus. The
vaccines will be distributed nationally after the initial lots become
available, which is expected within the next four weeks. 21 Sept 2009
World Alzheimer's Day: report shows more
than 35 million with dementia worldwide
Alzheimer's Disease International (ADI) has released a new report to
mark World Alzheimer's Day on 21 September 2009. It shows more than 35
million people will have dementia in 2010, a 10% increase over figures
reported in 2005, and a doubling nearly every 20 years. 21 Sept 2009.
Deutsch
Français
Español
Does government do enough for SMEs?
The UK Chartered Institute of Marketing has launched its latest Agenda
Paper, Access all areas? which asks what kind of help does government
really offer SMEs. 19 Sept 2009
New role discovered for vitamin C in
protecting the skin
Researchers at the University of Leicester and the Institute for
Molecular and Cellular Biology in Portugal have discovered new
protective properties of vitamin C in cells from the human skin. It
could lead to development of better skin-regeneration products. 19 Sept
2009
12th International Conference on Medical Image Computing and
Computer Assisted Intervention (MICCAI) London, 20-24 Sept. 19 Sept
2009
Sterilin secures laboratory supplies chain
in case of disruption from pandemic flu
British manufacturer Sterilin Ltd has geared up to ensure
‘pandemic-proof’ production and distribution of essential laboratory
testing supplies from its South Wales facility. 19 Sept 2009
Leica SCN400 slide scanner for optimal
histological examinations
The new Leica SCN400 Slide Scanner offers an alternative to the
microscope for the examination of histological samples in pathology,
research, and teaching. 19 Sept 2009
PROdesign launches 96-well plate
cell-feeding station for live cell imaging
PROdesign GmbH has launched the PROcellcare cell-feeding station
based on a 96-well plate. It supplies live cells (in vitro) under the
microscope with biological nutrient and working solutions thus allowing
the scientist/developer to execute efficient and automatic dispensing
and controlling processes of the equipment. 18 Sept 2009
Birmingham Children’s Hospital completes development of laboratory
system for newborn blood screening
Birmingham Children’s Hospital (BCH) has completed a project to improve
laboratory services for screening of newborn babies in the West
Midlands. A new laboratory system is being used to manage the
screening of bloodspots, taken by heelprick from 70,000 newborn infants
each year. 17 Sept 2009
UK Nanotechnology Knowledge Transfer
Network supports €1 billion EC investment in technology
The Nanotechnology Knowledge Transfer Network (NanoKTN), one of the UK’s
primary knowledge-based networks for Micro and Nanotechnologies, has
announced its support for the €1bn that has been made available by the
European Commission for new projects. 17 September 2009
PrimerDesign develops world's first test
kit for Tamiflu-resistant swine flu
Gene detection specialists PrimerDesign have developed a swine flu test
kit that identifies the Tamiflu-resistant strain within 2 hours compared
to the usual three days. 11 Sept 2009
Gold-coated nanotubes used as imaging agent
to detect tumour cells
The imaging agents could be used as a more efficient and less toxic
alternative to nanoparticles and fluorescent labels used in targeted
molecular detection of normal cells, cancer cells and bacteria. 11 Sept
2009
European pharmaceutical companies ahead of
US in drug discovery
A new analysis of 20 years of data contradicts previously published
claims that United States pharmaceutical companies are better innovators
than their European counterparts, and questions whether Americans
actually benefit from the higher prices they pay for many prescription
medications. 11 Sept 2009
First evidence of virus in prostate cancer
cells
A type of virus known to cause leukemia and sarcomas in animals has been
found for the first time in malignant human prostate cancer cells. If it
is proven to cause the cancer it would open opportunities for developing
diagnostic tests, vaccines, and therapies for treatment. 11 Sept 2009
Encap in colonic drug delivery licensing
deal with London University
London University's drug delivery system, Phloral, has unique coating
technology designed to target the release of drugs to the colon and will
form part of a range of colonic delivery systems promoted by Encap under
the name Encode. 10 Sept 2009
Siemens and SurgiVision to develop
MRI-guided cardiac electrophysiology system
The companies will partner to develop and commercialize a real-time
MRI-guided cardiac electrophysiology (EP) system. They will also
collaborate with the University of Utah to bring it to the clinic stage.
10 Sept 2009
First patient implanted with St Jude's Brio
neurostimulator
St. Jude Medical, Inc. has announced the first implant of the Brio
neurostimulator and the EU approval of the device, which it claims is
the world’s smallest, longest-lasting rechargeable deep brain
stimulation (DBS) device for treating the symptoms of Parkinson’s
disease. 10 Sept 2009
Education and defibrillators needed to
reduce sudden death during sport
More widespread availability of defibrillators and education of the
general public could boost survival rates fourfold amongst athletes
suffering cardiac arrest. 10 Sept 2009
Reperfusion therapy can cut risk of dying
from heart attack by half
Effective reperfusion therapy provides a timely and sustainable
reopening of the blockage. The wider use of reperfusion therapy in
patients with heart attack (AMI) can save millions of lives. 10 Sept
2009
Mederi Therapeutics launches radiotherapy
treatment for bowel incontinence
The Secca therapy delivers radiofrequency energy to the muscles of the
anal canal, which tightens the muscles, producing better bowel control
and reducing the symptoms of incontinence. 10 Sept 2009
PerkinElmer launches multiple steroid
diagnostic kit for hormone and endocrine disorders
The Child Health System steroid profiling kit and data suite software
can simultaneously measure ten different steroids in biological samples
for diagnosing hormone imbalances or endocrine diseases in both children
and adults. 10 Sept. Espanol
IDRI licenses NanoPass microneedle
technology for intradermal delivery
IDRI has licensed NanoPass' proprietary MicronJet microneedle technology
for the intradermal delivery of products against a number of diseases
including tuberculosis, HIV, malaria, leishmaniasis and leprosy. 10 Sept
2009
Illumina delivers first individual's genome
sequence through new service
Illumina, Inc. has delivered the genome sequence for the first customer
of its new gene sequencing service. It points to a future where genome
sequencing will become a routine practice that will enable physicians to
make better healthcare decisions for the individual. 5 September 2009
St Jude Medical announces European launch
of remote cardiac care network
The Merlin.net Patient Care Network (PCN) is a secure, Internet-based
remote care system for patients with implanted medical devices. It
gathers and stores data from the implant procedure, in-clinic follow-up
visits and from remote transmissions sent from a patient’s home. 5 Sept
2009
NeuroLogica announces FDA clearance for
inSPira HD: portable high resolution SPECT
The inSPira HD is a battery-powered, high resolution, portable SPECT
designed primarily for brain imaging. 5 Sept 2009
TransEnterix lauds study results for
minimally invasive laparoscopic surgical platform
Surgeons from the United States and Paraguay have successfully performed
first-in-man studies of TransEnterix's revolutionary single-incision,
single-port, four-channel laparoscopic surgical platform called the
SPIDER System. 5 Sept 2009
GE Healthcare and TomTec Imaging Systems
co-operate in cardiology IT
GE Healthcare and TomTec Imaging Systems GmbH, have entered into a
formal strategic co-operation contract to improve their echocardiography
systems. 5 Sept 2009
New TRUST trial data confirms clinical
benefits of home cardiac monitoring
Trial data demonstrates the benefits of the Biotronik Home Monitoring
system in the early detection of patient clinical events as well as the
safe reduction of in-office follow-up visits. 5 Sept 2009.
Deutsch
PsychoGenics and AstraZeneca in agreement
to identify new treatments for central nervous system disorders. 5
Sept 2009
Sectra signs multi-year contract with
Nordic region’s largest radiology company
Sectra and Norwegian company Curato have signed a six-year partnership
agreement for Sectra’s RIS/PACS products and services in a contract
worth about SEK 100 million. 5 Sept 2009
Bruker announces availability of world’s
first 18 Tesla FTMS magnet
This will open up new capabilities in mass spectrometry in a variety of
research areas, including protein identification, petroleomics,
metabolomics, small molecule tissue molecular imaging, and environmental
sample analysis. 5 Sept 2009.
Deutsch
Swansea Centre for Nanohealth awarded £1m
to study safety of nanoparticles
Researchers at Swansea University’s Centre for NanoHealth have been
awarded a £1 million grant to analyse the levels at which nanoparticles
can be deemed safe within cells. 5 Sept 2009
World-first swine-flu vaccine trial reveals one dose provides 'strong
immune response'
A clinical trial in the UK of Novartis MF59-adjuvanted cell-based A (H1N1) vaccine indicates that the vaccine is well-tolerated and one dose elicits
a strong immune response. 5 Sept 2009
Cause of neurological interference by
carbon nanotubes discovered
A team of Brown University researchers in the US has found that the
cause is the metal catalysts used to form the tubes, especially the
metal yttrium. 1 September 2009
Diagnostic Hybrids releases Thyretain for
specific detection of thyroid stimulating immunoglobulin
Thyretain is the first FDA-cleared test that specifically detects TSI
and is to be used as an aid in the differential diagnosis of Graves’
disease, an autoimmune thyroid disorder.1 September 2009
Space
Shuttle carries vaccine processing platform to International Space
Station
The Space Shuttle Discovery carried a scientific payload for the
International Space Station from Austin-based Astrogenetix that will
help develop vaccine candidates for MRSA and Salmonella. 1
September 2009
Opsonic Therapeutics to develop RAS and
mRNA technology from Tripep and Cosmix. 1 September 2009
MicroPhage opens clinical trial on
bacteriophage-based platform to identify MRSA
The MicroPhage platform is based on bacteriophage amplification to
rapidly identify bacterial infections and determine antibiotic
susceptibility. 1 September 2009
The US NIH awards Advaxis $210,000 for the
development of dual antigen vaccine
Advaxis has been awarded the grant from the US National Institutes of
Health to develop a single bioengineered Listeria monocytogenes
vaccine to deliver two different antigen-adjuvant proteins. 1 September
2009
Cerus’ Intercept blood system receives
Swiss approval. 1 September
3M introduces first electronic stethoscope
with Bluetooth wireless
3M has introduced the 3M Littmann Electronic Stethoscope Model 3200, a
next-generation auscultation device featuring Bluetooth technology that
wirelessly transfers heart, lung and other body sounds to computer
systems software for further analysis. 1 September 2009
The Gambia launches national vaccination
campaign against child-killing disease
The Gambia has launched a national immunisation programme with the help
of the GAVI Alliance to eradicate pneumococcal disease, one of the
leading causes of child death worldwide. 1 September 2009
Francais
CLC bio delivers specialised
immunoinformatics solution to Symphogen
CLC bio has completed a specialized immunoinformatics system that is
fully customized to fit into Symphogen’s proprietary Symplex technology
for high throughput identification of antibodies with diversity and
specificity customized to a particular therapeutic application. 1
September 2009
August 2009 >>
2009
Jan |
Feb |
Mar |
Apr |
May |
Jun |
Jul |
Aug |
2008
Jan |
Feb |
Mar |
Apr |
May |
Jun |
Jul |
Aug |
Sep |
Oct |
Nov |
Dec
2007
Jan |
Feb |
Mar |
Apr |
May |
Jun |
Jul |
Aug |
Sep |
Oct |
Nov |
Dec
2006
Jan |
Feb |
Mar |
Apr |
May |
Jun |
Jul |
Aug |
Sep |
Oct |
Nov |
Dec
2005
Jan |
Feb |
Mar |
Apr |
May |
Jun |
Jul |
Aug |
Sep |
Oct |
Nov |
Dec